Cargando…
Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines
BACKGROUND: Soft-tissue sarcomas (STS) are a diverse group of malignancies that remain a diagnostic and therapeutic challenge. Relatively few reliable cell lines currently exist. Rapidly developing technology for genomic profiling with emerging insights into candidate functional (driver) aberrations...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117779/ https://www.ncbi.nlm.nih.gov/pubmed/27560552 http://dx.doi.org/10.1038/bjc.2016.259 |
_version_ | 1782468866729836544 |
---|---|
author | Salawu, Abdulazeez Fernando, Malee Hughes, David Reed, Malcolm W R Woll, Penella Greaves, Claire Day, Chris Alhajimohammed, Meshal Sisley, Karen |
author_facet | Salawu, Abdulazeez Fernando, Malee Hughes, David Reed, Malcolm W R Woll, Penella Greaves, Claire Day, Chris Alhajimohammed, Meshal Sisley, Karen |
author_sort | Salawu, Abdulazeez |
collection | PubMed |
description | BACKGROUND: Soft-tissue sarcomas (STS) are a diverse group of malignancies that remain a diagnostic and therapeutic challenge. Relatively few reliable cell lines currently exist. Rapidly developing technology for genomic profiling with emerging insights into candidate functional (driver) aberrations raises the need for more models for in vitro functional validation of molecular targets. METHODS: Primary cell culture was performed on STS tumours utilising a differential attachment approach. Cell lines were characterised by morphology, immunocytochemistry, proliferation assays, short tandem repeat (STR) and microarray-based genomic copy number profiling. RESULTS: Of 47 STS cases of various subtypes, half formed adherent monolayers. Seven formed self-immortalised cell lines, including three undifferentiated pleomorphic sarcomas, two dedifferentiated liposarcomas (one of which had received radiotherapy), a leiomyosarcoma and a myxofibrosarcoma. Two morphologically distinct yet genetically identical variants were established in separate cultures for the latter two tumours. All cell lines demonstrated genomic and phenotypic features that not only confirm their malignant characteristics but also confirm retention of DNA copy number aberrations present in their parent tumours that likely include drivers. CONCLUSIONS: These primary cell lines are much-needed additions to the number of reliable cell lines of STS with complex genomics available for initial functional validation of candidate molecular targets. |
format | Online Article Text |
id | pubmed-5117779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51177792017-10-25 Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines Salawu, Abdulazeez Fernando, Malee Hughes, David Reed, Malcolm W R Woll, Penella Greaves, Claire Day, Chris Alhajimohammed, Meshal Sisley, Karen Br J Cancer Translational Therapeutics BACKGROUND: Soft-tissue sarcomas (STS) are a diverse group of malignancies that remain a diagnostic and therapeutic challenge. Relatively few reliable cell lines currently exist. Rapidly developing technology for genomic profiling with emerging insights into candidate functional (driver) aberrations raises the need for more models for in vitro functional validation of molecular targets. METHODS: Primary cell culture was performed on STS tumours utilising a differential attachment approach. Cell lines were characterised by morphology, immunocytochemistry, proliferation assays, short tandem repeat (STR) and microarray-based genomic copy number profiling. RESULTS: Of 47 STS cases of various subtypes, half formed adherent monolayers. Seven formed self-immortalised cell lines, including three undifferentiated pleomorphic sarcomas, two dedifferentiated liposarcomas (one of which had received radiotherapy), a leiomyosarcoma and a myxofibrosarcoma. Two morphologically distinct yet genetically identical variants were established in separate cultures for the latter two tumours. All cell lines demonstrated genomic and phenotypic features that not only confirm their malignant characteristics but also confirm retention of DNA copy number aberrations present in their parent tumours that likely include drivers. CONCLUSIONS: These primary cell lines are much-needed additions to the number of reliable cell lines of STS with complex genomics available for initial functional validation of candidate molecular targets. Nature Publishing Group 2016-10-25 2016-08-25 /pmc/articles/PMC5117779/ /pubmed/27560552 http://dx.doi.org/10.1038/bjc.2016.259 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Translational Therapeutics Salawu, Abdulazeez Fernando, Malee Hughes, David Reed, Malcolm W R Woll, Penella Greaves, Claire Day, Chris Alhajimohammed, Meshal Sisley, Karen Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines |
title | Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines |
title_full | Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines |
title_fullStr | Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines |
title_full_unstemmed | Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines |
title_short | Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines |
title_sort | establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines |
topic | Translational Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117779/ https://www.ncbi.nlm.nih.gov/pubmed/27560552 http://dx.doi.org/10.1038/bjc.2016.259 |
work_keys_str_mv | AT salawuabdulazeez establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines AT fernandomalee establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines AT hughesdavid establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines AT reedmalcolmwr establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines AT wollpenella establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines AT greavesclaire establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines AT daychris establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines AT alhajimohammedmeshal establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines AT sisleykaren establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines |